| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | — | +544.2% |
| Cost of Revenue | $5.3M | — | +2754.9% |
| R&D Expense | $7.8M | — | +25.4% |
| SG&A Expense | $12.8M | — | -35.2% |
| Operating Income | -$27.3M | — | +89.5% |
| Pre-tax Income | -$30.8M | — | +87.9% |
| Income Tax | -$3.0M | — | -117.2% |
| Net Income | -$20.8M | — | +85.5% |
| EPS (Basic) | -$0.27 | — | +91.3% |
| EPS (Diluted) | -$0.27 | — | +91.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $55.4M | -8.4% | — |
| Accounts Receivable | $840K | -23.2% | +254.4% |
| Inventory | $1.6M | -2.6% | -70.1% |
| Current Assets | $81.8M | -1.6% | +695.6% |
| Total Assets | $591.5M | -1.3% | -10.4% |
| Current Liabilities | $59.8M | -21.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$34.0M | — | -131.6% |
| Capital Expenditures | $846K | — | -7.7% |
| Investing Cash Flow | -$846K | — | +74.0% |
| Financing Cash Flow | $29.8M | — | +263.1% |
| Free Cash Flow | -$34.9M | — | -123.4% |
| +26.5% |
| Long-term Debt | $6.9M | -16.7% | -43.8% |
| Total Liabilities | $93.3M | -19.2% | -11.9% |
| Stockholders' Equity | $223.4M | +9.4% | -14.6% |